{"a":[{"_":"Attovia, Braveheart and Vogenx seek more than $500M across trio of IPOs","$":{"href":"/biotech/attovia-braveheart-and-vogenx-seek-more-500m-ipos","hreflang":"en"}}]}

Summary

Attovia Therapeutics, Braveheart Bio, and Vogenx have set target ranges for their initial public offerings, collectively seeking more than $500 million from public investors.